MedPath

Scios, Inc.

Scios, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1981-01-01
Employees
509
Market Cap
-
Website

Clinical Trials

22

Active:0
Completed:20

Trial Phases

4 Phases

Phase 1:1
Phase 2:8
Phase 3:8
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials

Phase 2
8 (44.4%)
Phase 3
8 (44.4%)
Phase 1
1 (5.6%)
Phase 4
1 (5.6%)

Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS

Phase 4
Completed
Conditions
Congestive Heart Failure
Chronic Heart Failure
First Posted Date
2008-04-04
Last Posted Date
2011-05-19
Lead Sponsor
Scios, Inc.
Registration Number
NCT00652652

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

Phase 2
Completed
Conditions
Coronary Artery Bypass Surgery
Coronary Heart Disease
Coronary Artery Bypass Grafting
Cardiopulmonary Bypass
Ischemic Heart Disease
Congestive Heart Failure
First Posted Date
2008-04-04
Last Posted Date
2011-05-19
Lead Sponsor
Scios, Inc.
Target Recruit Count
305
Registration Number
NCT00653042

An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)

Phase 3
Withdrawn
Conditions
Coronary Artery Bypass Surgery
Coronary Heart Disease
Ischemic Heart Disease
Coronary Artery Bypass Grafting
Cardiopulmonary Bypass
Heart Failure, Congestive
First Posted Date
2007-09-17
Last Posted Date
2016-09-20
Lead Sponsor
Scios, Inc.
Registration Number
NCT00530361

Heart Failure Registry

Completed
Conditions
Heart Failure, Congestive
First Posted Date
2007-09-17
Last Posted Date
2014-01-31
Lead Sponsor
Scios, Inc.
Target Recruit Count
150000
Registration Number
NCT00530426

A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

Phase 1
Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2007-07-30
Last Posted Date
2011-05-19
Lead Sponsor
Scios, Inc.
Target Recruit Count
16
Registration Number
NCT00508768
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.